PT Kalbe Farma Tbk 2024 SR
The report highlights Kalbe's commitment to 'Together Building a Healthy Nation' through its ERAT and SEHAT pillars. Key achievements in 2024 include expanding healthcare access via generic drugs and digital platforms like One Onco and KlikDiabetes. Environmentally, the company increased its solar panel capacity to 8.5 MWp and reduced emissions through electric vehicle distribution. Socially, it focused on stunting reduction programs and supporting over 9,000 red ginger farmers. The report follows GRI Standards 2021 and SASB Biotechnology & Pharmaceuticals guidelines.
Company: PT Kalbe Farma Tbk
Sector: Health Care
Country: Indonesia
Year: 2024
Type: SR
Pages: 120
Back to company
PT Kalbe Farma Tbk
Sustainability Report
The report highlights Kalbe's commitment to 'Together Building a Healthy Nation' through its ERAT and SEHAT pillars. Key achievements in 2024 include expanding healthcare access via generic drugs and digital platforms like One Onco and KlikDiabetes. Environmentally, the company increased its solar panel capacity to 8.5 MWp and reduced emissions through electric vehicle distribution. Socially, it focused on stunting reduction programs and supporting over 9,000 red ginger farmers. The report follows GRI Standards 2021 and SASB Biotechnology & Pharmaceuticals guidelines.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Apr 1, 2025
Type
Sustainability Report
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees